A shadow economy for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.
Experimental Drug Gaining Traction Online
Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to contact these profiles directly for source information, while also receiving discount codes.
Thriving Trade on Social Networks
Additionally, a flourishing market exists on Telegram, where communities with thousands of members share “before and after” photos, administration instructions and claims of next-day British shipping. Vendors market the drug there before redirecting buyers to WhatsApp for transactions.
Learning About The Experimental Drug
This medication is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist individuals lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.
Healthcare Experts Voice Concerns
However, physicians and pharmacists have warned that the sale of what remains an unlicensed medication in the UK is a cause for concern and could result in individuals injecting products of unknown origin.
Some professionals said the demand for retatrutide could be connected to the rising price of licensed slimming treatments such as Mounjaro.
Legal Position and Implementation
Marketing retatrutide on social media or messaging apps is prohibited in the UK, as it is an unapproved medication that cannot be promoted or supplied for human use under the British medical regulations.
Several content creators attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate medicines, marketing, and consumer regulations, risking fines, legal action or imprisonment.
Platform Reaction and Content Removal
Based on the social media company, the service has removed problematic content and banned related keywords and search suggestions. The organization stated it was dedicated to keeping the platform safe and investing in strengthening enforcement strategies.
Online Marketplace Activities
Investigations also discovered groups with up to nine thousand members selling the experimental drug using Telegram's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” immediately displays groups with numerous of users, filled with photos of weight loss, glowing testimonials and step-by-step instructions for preparing or administering at home.
Within moments of entering one group, a seller shared WhatsApp details, where the majority of purchases take place. The seller provided an instruction manual and promised shipping within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one inquired about weight, medical conditions or previous experience.
Product Information and Costs
Within these groups, messages display black plastic packages with Royal Mail labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at residence with purified liquid, or ready-to-use injectors usually priced at £160 for 20mg. When asked how much time a injector should be used, sellers give contradictory answers varying between a few weeks to “depends on your body”.
Platform Oversight and Security Actions
A spokesperson for the messaging service stated it regularly moderated harmful content on its service including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are administering substances they cannot confirm. Although the research behind this drug is valid, these online versions may not include what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor linked the surge in interest to recent price rises for authorized weight-loss drugs such as Mounjaro. “With costs rising, individuals are using social media. But fake injections are highly dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.
Her staff has already encountered individuals harmed by self-injection from unverified sources. “We understand the frustration, but purchasing from Telegram or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”
Manufacturer Position
A representative from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a company investigational substance not yet authorized … may expose users to potentially serious health risks”.
